Inventor · disambiguated record
Yile Chen
Also filed as: CHEN YILE
3 granted patents·4 pending applications·4 citations·filing 2016–2022
53Inventor score
Files withACEA THERAPEUTICS INC4MINGHUI PHARMACEUTICAL HANGZHOU LTD2MINGHUI PHARMACEUTICAL SHANGHAI LTD1
Top patents by PatentIndex Score
7 records- 0176US10533011B2Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making sameACEA THERAPEUTICS INC·Filed 2016·Granted Jan 14, 2020·4 cites·25 claims
- 0256US2025136576A1Heterocyclic Compounds and Uses ThereofACEA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0352US2024358848A1Antitumor compound and use thereofMINGHUI PHARMACEUTICAL HANGZHOU LTD·Filed 2022·Application pending·0 cites
- 0451US2024132515A1Toxin molecule suitable for antibody-drug conjugateMINGHUI PHARMACEUTICAL HANGZHOU LTD·Filed 2022·Application pending·0 cites
- 0547US12358895B2Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereofACEA THERAPEUTICS INC·Filed 2018·Granted Jul 15, 2025·0 cites·18 claims
- 0643US2023099739A1Jak kinase inhibitor and preparation and application thereofMINGHUI PHARMACEUTICAL SHANGHAI LTD·Filed 2021·Application pending·0 cites
- 0741US11498922B2Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamideACEA THERAPEUTICS INC·Filed 2017·Granted Nov 15, 2022·0 cites·16 claims
Join the waitlist — get patent alerts
Get an alert when Yile Chen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →